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Background
The cGMP pathway regulates a large spectrum of physio-
logical processes including metabolism. Our aim is to
elucidate the cGMP signaling cascade in adipose tissue.
Two types of fat tissue can be distinguished in mammals:
white adipose tissue (WAT), which is the biggest storage
of energy, and brown fat (BAT) that can dissipate energy
as heat (non-shivering thermogenesis). We and others
found that cGMP enhances differentiation of brown and
white adipocytes [1-4].
Methods and results
In our studies, we initially focused on protein kinase G
(PKG/cGK), which is expressed both in white and brown
adipocytes. Using gain- and loss-of-function models, we
found that PKG is the major receptor for cGMP in brown
adipocytes. We investigated the downstream targets
of PKG and found a novel negative feedback loop that reg-
ulates cGMP levels. Importantly, in the presence of
increased cGMP levels, we found an enhanced develop-
ment of brown-like adipocytes, so-called beige or brite
(brown in white) cells both in vitro and in vivo. These data
indicate that cGMP not only enhances development of
“classical” brown adipocytes, but also promotes develop-
ment of beige cells.
Therefore, we studied the effect of cGMP in white adi-
pocytes in more detail. Lentiviral overexpression of PKG
enhanced differentiation of white adipocytes. Moreover,
PKG induced the expression of a brown-like adipogenic
program in white fat cells. Treatment of mice with
the PDE inhibitor sildenafil for only 7 days promoted
“browning” of WAT. Further studies regarding the cGMP
signaling cascade upstream of PKG revealed that both par-
ticulate as well as soluble guanylyl cyclases are the source
of cGMP in adipocytes.
Conclusion
In conclusion, cGMP is essential for normal differentiation
of white and brown adipocytes. The cGMP/PKG pathway
also induces “browning” of white fat and thus could be a
promising target for developing novel therapies to treat
metabolic diseases that are associated with imbalances in
energy homeostasis including obesity and cachexia.
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